Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12607000276459Phase 3Not yet recruiting
Phase 3, randomised, open-label trial of dextrose, lidocaine and ropivacaine in chronic Achilles tendinopathy (2 arms), sponsored by Griffith University. Primary endpoint: Victorian Institute of Sport Assessment - Achilles (VISA-A) questionnaire at 12 months. Planned start Jun 2007; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12607000276459.